226 related articles for article (PubMed ID: 16123159)
1. Medroxyprogesterone acetate induces cell proliferation through up-regulation of cyclin D1 expression via phosphatidylinositol 3-kinase/Akt/nuclear factor-kappaB cascade in human breast cancer cells.
Saitoh M; Ohmichi M; Takahashi K; Kawagoe J; Ohta T; Doshida M; Takahashi T; Igarashi H; Mori-Abe A; Du B; Tsutsumi S; Kurachi H
Endocrinology; 2005 Nov; 146(11):4917-25. PubMed ID: 16123159
[TBL] [Abstract][Full Text] [Related]
2. Biphasic effect of medroxyprogesterone-acetate (MPA) treatment on proliferation and cyclin D1 gene transcription in T47D breast cancer cells.
Thuneke I; Schulte HM; Bamberger AM
Breast Cancer Res Treat; 2000 Oct; 63(3):243-8. PubMed ID: 11110058
[TBL] [Abstract][Full Text] [Related]
3. Essential roles of PI-3K/Akt/IKKbeta/NFkappaB pathway in cyclin D1 induction by arsenite in JB6 Cl41 cells.
Ouyang W; Li J; Ma Q; Huang C
Carcinogenesis; 2006 Apr; 27(4):864-73. PubMed ID: 16387740
[TBL] [Abstract][Full Text] [Related]
4. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
Wu J; Brandt S; Hyder SM
Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
[TBL] [Abstract][Full Text] [Related]
5. Rottlerin inhibits the nuclear factor kappaB/cyclin-D1 cascade in MCF-7 breast cancer cells.
Torricelli C; Fortino V; Capurro E; Valacchi G; Pacini A; Muscettola M; Soucek K; Maioli E
Life Sci; 2008 Mar; 82(11-12):638-43. PubMed ID: 18261747
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
Mabuchi S; Ohmichi M; Nishio Y; Hayasaka T; Kimura A; Ohta T; Kawagoe J; Takahashi K; Yada-Hashimoto N; Seino-Noda H; Sakata M; Motoyama T; Kurachi H; Testa JR; Tasaka K; Murata Y
Clin Cancer Res; 2004 Nov; 10(22):7645-54. PubMed ID: 15569997
[TBL] [Abstract][Full Text] [Related]
7. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
Chen J; Zeng J; Xin M; Huang W; Chen X
Horm Metab Res; 2011 Sep; 43(10):681-6. PubMed ID: 21932171
[TBL] [Abstract][Full Text] [Related]
8. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
9. Medroxyprogesterone acetate attenuates estrogen-induced nitric oxide production in human umbilical vein endothelial cells.
Oishi A; Ohmichi M; Takahashi K; Takahashi T; Mori-Abe A; Kawagoe J; Otsu R; Mochizuki Y; Inaba N; Kurachi H
Biochem Biophys Res Commun; 2004 Nov; 324(1):193-8. PubMed ID: 15465001
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid promotes proliferation of chicken primordial germ cells via activation of PI3K/Akt-mediated NF-κB signalling cascade.
Yu M; Ge C; Zeng W; Mi Y; Zhang C
Cell Biol Int; 2012 Aug; 36(8):705-12. PubMed ID: 22548360
[TBL] [Abstract][Full Text] [Related]
11. Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFkappaB activation and cyclin D1 up-regulation.
Ho YS; Chen CH; Wang YJ; Pestell RG; Albanese C; Chen RJ; Chang MC; Jeng JH; Lin SY; Liang YC; Tseng H; Lee WS; Lin JK; Chu JS; Chen LC; Lee CH; Tso WL; Lai YC; Wu CH
Toxicol Appl Pharmacol; 2005 Jun; 205(2):133-48. PubMed ID: 15893541
[TBL] [Abstract][Full Text] [Related]
12. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Cx43 phosphorylation in 5'-N-ethylcarboxamide-induced migration and proliferation of mouse embryonic stem cells.
Kim MO; Lee YJ; Han HJ
J Cell Physiol; 2010 Jul; 224(1):187-94. PubMed ID: 20232318
[TBL] [Abstract][Full Text] [Related]
15. Blocking of Akt/NF-kappaB signaling by pentoxifylline inhibits platelet-derived growth factor-stimulated proliferation in Brown Norway rat airway smooth muscle cells.
Chiou YL; Shieh JJ; Lin CY
Pediatr Res; 2006 Dec; 60(6):657-62. PubMed ID: 17065572
[TBL] [Abstract][Full Text] [Related]
16. Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action.
Yakes FM; Chinratanalab W; Ritter CA; King W; Seelig S; Arteaga CL
Cancer Res; 2002 Jul; 62(14):4132-41. PubMed ID: 12124352
[TBL] [Abstract][Full Text] [Related]
17. Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer.
Cerliani JP; Guillardoy T; Giulianelli S; Vaque JP; Gutkind JS; Vanzulli SI; Martins R; Zeitlin E; Lamb CA; Lanari C
Cancer Res; 2011 May; 71(10):3720-31. PubMed ID: 21464042
[TBL] [Abstract][Full Text] [Related]
18. Daintain/AIF-1 promotes breast cancer proliferation via activation of the NF-kappaB/cyclin D1 pathway and facilitates tumor growth.
Liu S; Tan WY; Chen QR; Chen XP; Fu K; Zhao YY; Chen ZW
Cancer Sci; 2008 May; 99(5):952-7. PubMed ID: 18341653
[TBL] [Abstract][Full Text] [Related]
19. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
Rivas MA; Carnevale RP; Proietti CJ; Rosemblit C; Beguelin W; Salatino M; Charreau EH; Frahm I; Sapia S; Brouckaert P; Elizalde PV; Schillaci R
Exp Cell Res; 2008 Feb; 314(3):509-29. PubMed ID: 18061162
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
Giulianelli S; Vaqué JP; Soldati R; Wargon V; Vanzulli SI; Martins R; Zeitlin E; Molinolo AA; Helguero LA; Lamb CA; Gutkind JS; Lanari C
Cancer Res; 2012 May; 72(9):2416-27. PubMed ID: 22396492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
